| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238720 Pharmaceutical use of N-carbamoylazole derivatives |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238698 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis. |
| 07/03/2007 | US7238697 Insecticides for crops |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | CA2211312C Alkylene oxide catalyst and process |
| 07/03/2007 | CA2188306C Process for the diastereoselective synthesis of nucleoside analogues |
| 07/03/2007 | CA2168021C Vasoconstrictive dihydrobenzopyran derivatives |
| 06/28/2007 | WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | WO2007073300A1 Gaba-b receptor modulators |
| 06/28/2007 | WO2007073299A1 Imidazoles as gaba-b receptor modulators |
| 06/28/2007 | WO2007073298A1 Imidazole derivatives for the treatment of gastrointestinal disorders |
| 06/28/2007 | WO2007073297A1 Pyrazoles for the treatment of gerd and ibs |
| 06/28/2007 | WO2007073284A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES |
| 06/28/2007 | WO2007072999A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | WO2007072782A1 Carboxylic acid derivative or salt thereof |
| 06/28/2007 | WO2007072150A2 Piperidine derivatives |
| 06/28/2007 | WO2007072146A1 Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 06/28/2007 | WO2007072093A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | WO2007072088A1 Process for the production of ezetimibe and intermediates used in this proces |
| 06/28/2007 | WO2007071963A2 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 06/28/2007 | WO2007071961A1 Benzamide derivatives |
| 06/28/2007 | WO2007071956A1 Novel benzamide derivatives |
| 06/28/2007 | WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 06/28/2007 | WO2007071396A2 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | WO2007071035A1 Heterocyclic amide derivatives as calcium channel blockers |
| 06/28/2007 | WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
| 06/28/2007 | WO2007022938A3 Compounds |
| 06/28/2007 | US20070149793 Heterogeneous ruthenium catalyst, nucleus-hydrogenated diglycidyl ether of bisphenols a and f, and method for the production thereof |
| 06/28/2007 | US20070149613 Fumagillol derivative and the medical use thereof |
| 06/28/2007 | US20070149612 6-fluorochroman derivatives as chemical intermediates for preparing Nebivolol; adrenergic beta-antagonist, an antihypertensive agent, anticoagulants and a vasodilating agent; low cost, improved overall yield |
| 06/28/2007 | US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 06/28/2007 | US20070149603 Ppar active compounds |
| 06/28/2007 | US20070149600 Substituted octahydroisoindoles |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149566 e.g. 4-({(E)-4-[(2-carboxy-6-fluoro-4-quinolinyl)oxy]-2-butenyl}oxy)-6-fluoroquinoline-2-carboxylic acid; antidiabetic, hypoglycemic agent; type II diabetes, dyslipidaemia, obesity, arterial hypertension, atherosclerosis, microangiopathy, macroangiopathy, retinopathy, neuropathy or hyperglycaemia |
| 06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070149558 Benzo-fused 5-membered heterocyclic compounds, their production and use |
| 06/28/2007 | US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 06/28/2007 | US20070149542 Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 06/28/2007 | US20070149537 NK1 and NK2-antagonists and compositions and methods of using the same |
| 06/28/2007 | US20070149533 Bicyclic compounds with kinase inhibitory activity |
| 06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 06/28/2007 | US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof |
| 06/28/2007 | US20070149503 Anti-migraine spirocycles |
| 06/28/2007 | US20070149502 Spirocyclic anti-migraine compounds |
| 06/28/2007 | US20070149406 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives |
| 06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070148680 Detection of disease related genes |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | CA2634804A1 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/28/2007 | CA2634172A1 Piperidine derivatives |
| 06/28/2007 | CA2633457A1 Heterocyclic amide derivatives as calcium channel blockers |
| 06/28/2007 | CA2633207A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | CA2632929A1 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 06/28/2007 | CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs |
| 06/28/2007 | CA2632582A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | CA2632021A1 Gaba-b receptor modulators |
| 06/28/2007 | CA2632020A1 Imidazoles as gaba-b receptor modulators |
| 06/28/2007 | CA2632016A1 Imidazole derivatives for the treatment of gastrointestinal disorders |
| 06/28/2007 | CA2632011A1 Pyrazoles for the treatment of gerd and ibs |
| 06/28/2007 | CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | CA2630737A1 Process for the production of ezetimibe and intermediates used in this process |
| 06/28/2007 | CA2629991A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/27/2007 | EP1801111A1 Novel polymorph forms of olmesartan medoxomil |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1801103A1 Preparation of 2-((2,3- dihydro-benzo(1,4) dioxin-5-YL)-(2-hydroxyethyl)-amino)-ethanol and related intermediates |
| 06/27/2007 | EP1799674A1 New piperidine antibiotics |
| 06/27/2007 | EP1799648A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799206A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/27/2007 | EP1740574B1 4-amino-5-cyanopyrimidine derivatives |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1140873B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/27/2007 | CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 06/27/2007 | CN1989103A Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 06/27/2007 | CN1989099A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 06/27/2007 | CN1988907A Dual small molecule inhibitors of cancer and angiogenesis |
| 06/27/2007 | CN1986543A Cancer chemotherapy |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235675 Conjugates of mycophenolic acid |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |
| 06/26/2007 | US7235663 E.g., 2,6-Diethyl-4,4-dimethoxy-2,3,6-trimethyl-1-(1-(4-oxir-anylmethoxy-phenyl) -ethoxy)-piperidine or 7,9-Diethyl-2,6, 7,9-tetramethyl-8-(1-(4-oxiranylmethoxy-phenyl)-ethoxy)-1,4-dioxa-8-aza -spiro(4.5)decane; anionic polymerization |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235611 Triazine compounds, polymers comprising triazine structural units, and method |
| 06/26/2007 | US7235584 Dibenzo[b,d]pyran derivatives as neuroprotectant, antiinflammatory, and antiischemic agents; brain, cardiovascular, neurodegenerative, autoimmune and nervous system disorders; Grave*s, Hashimoto*s, Alzheimer*s, Parkinson*s, and Huntington*s disease; amyotrophic lateral sclerosis; drug abuse, alcoholism |